From a medical cardiologist’s perspective, how do the threshold-setting targets of LDL-C levels of 70 mg/dL apply to PCSK9-based treatment for CV risk reduction? Did the guidelines emphasize sufficiently, the results of the CV outcome trials?

From a medical cardiologist’s perspective, how do the threshold-setting targets of LDL-C levels of 70 mg/dL apply to PCSK9-based treatment for CV risk reduction? Did the guidelines emphasize sufficiently, the results of the CV outcome trials?

CLICK HERE FOR CME CREDIT

From a medical cardiologist’s perspective, how do the threshold-setting targets of LDL-C levels of 70 mg/dL apply to PCSK9-based treatment for CV risk reduction? Did the guidelines emphasize sufficiently, the results of the CV outcome trials?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

R. Scott Wright, MD

R. Scott Wright, MD

Professor of Medicine Department of Cardiovascular Medicine Cardiovascular Division Mayo Clinic